Navigation Links
Now, Silica Nanobubbles for Targeted Drug Delivery

Indian researchers at the Indian Institute of Technology (IIT), Chennai, have succeeded in entrapping antibiotics within silica nanobubbles and delivering them into cells, a// major step towards drug efficacy.

The researchers have used the 'Core-shell system' that comprises a core of one material and a shell of another (inert) material.

The possibility of delivering therapeutic molecules into cells and monitoring it through fluorescence imaging has opened up new possibilities, claims Thalappil Pradeep, who led the team at IIT.

They incorporated ciprofloxacin (a known antibiotic) molecules on the gold nanoparticle surface with subsequent growth of a silica shell over that. This was followed by removal of the gold core -- using a method they have patented -- leaving behind a "nanobubble" inside which the antibiotic was trapped.

"A hollow nanobubble or nanoshell of silica (10-20 nm in diameter, 1-2 nm shell thickness) contains about 65 molecules of ciprofloxacin," Pradeep told IANS. (Human hair by comparison is 100,000 nanometres thick).

He said that they used sophisticated techniques like "fluorescence anisotropy" to show that the molecules are confined within the cage.

The advantage of such nanoscopic containers is they provide a rigid environment for the trapped molecules protecting them from unwanted chemical reactions, said Pradeep.

Though core-shell systems are known, "what is new in our work is the entrapment of antibiotics within nanoceramic shells and their delivery into cells", he said. The drug-loaded nanobubbles are stable and can be stored for extended periods.

In actual experiments, Pradeep and his colleagues incubated the shells containing the antibiotic (or a fluorescence label) with E. coli bacteria and observed the distribution of the drug inside the bacterium by fluorescence imaging technique.

In this work, the shells were not made specific to the cells, Pradeep explained. But that is possible by attaching appropriate antibodies to the nanobubbles that would allow them to 'home in' on target cells.

The work of Pradeep and fellow researchers is to appear in the prestigious journal 'Langmuir'.

"As the porosity of the shells is controllable, controlled release of drugs can be achieved," they said. "Furthermore, stability, ease of synthesis and bio-compatibility of silica shells make this system a better choice in comparison to other chemical analogues."

Source-IANS
'"/>




Related medicine news :

1. Gel Offers A More Targeted Approach
2. New Vaccine Targeted At Effective Treatment Against Tuberculosis
3. Doctors, Pharma Companies Targeted By CBI Raids
4. Treatment Resistant Tumors Can Be Targeted Better Using Botox
5. KFC Targeted in Lawsuit
6. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
7. Targeted Compound Helps Recurrent Prostate Cancer Patients
8. Tumors Targeted Naturally
9. New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs
10. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
11. Link between C-section Delivery and Stillbirth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian ... Bible teacher residing in North Carolina with his wife, Anna Marie. He and his ... six grandchildren. David is also the author of “Shadow and Substance.” , “Love, the ...
(Date:3/23/2017)... CO (PRWEB) , ... March 23, 2017 , ... A ... bar for entry into teacher preparation programs. The NCTQ report suggests, based on a ... entry requirements would significantly improve teacher quality in the U.S. It argues that this ...
(Date:3/23/2017)... ... March 23, 2017 , ... PAINWeekEnd (PWE) Oklahoma City, on ... Avenue, will be an educational and exciting program providing busy clinicians and allied ... chronic pain. , Oklahoma is in a healthcare crisis. The state ranks 46th ...
(Date:3/23/2017)... OH (PRWEB) , ... March ... ... insurance and financial services firm serving the families and businesses of the ... community enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... investment in Los Angeles based healthcare technology company California Healthcom Group (CHG). ... the US, and healthcare arena. With headquarters in California, CHG is a growing, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The IPF pipeline is very strong with a total of 97 drug ... Biogen and Sanofi are involved in the development of the IPF therapeutics. ... in Phase III stage, 15 are in Phase II stage, 12 are ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Supplies - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a ...
(Date:3/24/2017)... 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today disclosed terms ... Sheet (the "Definitive Financing") it entered into on ... stockholders, who are referred to in the Definitive ... filed with the Securities and Exchange Commission.   ...
Breaking Medicine Technology: